Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Vicor Corp's Chairman and CEO, Patrizio Vinciarelli, executed a sale of 47,922 common shares on March 16, 2026, under a pre-arranged 10b5-1 trading plan, generating $9.23 million in proceeds. The transactions were reported on a Form 4 filed with the Securities and Exchange Commission. Market data in the filing and subsequent trading show the share…
Thomas Beckett, senior vice president and general counsel at American Public Education (APEI), executed a Rule 10b5-1 sale of 2,000 shares on March 16, 2026, for $57.70 each, generating $115,400. The trade occurred while the stock traded close to its 52-week high and after the company reported a stronger-than-expected fourth quarter that prompted m…
A Stellus Capital Investment Corp director purchased 45,490 shares on March 13, 2026, in four transactions totalling $397,491, bringing his direct holdings to 228,055 shares. The move comes as the stock trades at $9.14, close to its 52-week low of $8.43, following a 9% drop in the past week. Separately, the company reported Q4 2025 results that mis…
Archer-Daniels-Midland Co (ADM) Senior Vice President Ian R. Pinner sold 34,106 shares on March 13, 2026, raising $2.44 million at a weighted average price of $71.53. The sale occurred as the stock trades close to its 52-week high. Following the disposition, Pinner retains direct ownership of 90,676 shares. The company recently reported mixed fourt…
Archer-Daniels-Midland Co. (ADM) Senior Vice President Christopher M. Cuddy sold 35,000 shares on March 13, 2026, generating $2.57 million at $73.5 per share. The transaction happened near the stock's 52-week high, while ADM recently reported a mixed fourth-quarter 2025 with adjusted EPS above expectations but revenue below forecasts. Corporate gov…
Monster Beverage Corp Chief Financial Officer Thomas J. Kelly executed several transactions on March 13 and 14, 2026, selling a total of 16,579 shares in multiple tranches and acquiring shares tied to vested performance units. The largest single sale was 8,000 shares at $77.22 for proceeds of $617,760. The stock is trading close to those levels whi…
Christopher James Kelley, Senior Vice President - Operations at Old Dominion Freight Line, sold 80 shares on Feb. 18, 2026, for $200.43 apiece, generating $16,034 in proceeds. The transaction occurred while the stock had rallied roughly 29% over six months, though InvestingPro's fair value view indicates the current market quote may exceed fair val…
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman sold 417 shares of company common stock on March 17, 2026, at $25.65 per share while exercising options to acquire an identical number of shares at $15.44. The transactions were carried out under a pre-arranged Rule 10b5-1 plan. The company reported an EPS beat for Q4 2025 and is prep…
Kenneth Koon Keung Lai, Bel Fuse's vice president of Asia operations, sold 552 shares of Class B common stock on March 16, 2026, generating $112,171. After the trade Lai holds 7,532 shares. The disposal occurred as Bel Fuse shares traded near $209.52, up about 173% over the past year. The company also reported fourth-quarter results that topped ana…
Stephen Dawson, president of Bel Fuse Inc's Power Solutions unit, disposed of 3,444 shares of Class B common stock on March 16, 2026, generating $699,855 in proceeds. The sale followed a restricted stock grant and comes as the shares have rallied sharply over the past year. Recent company results and analyst revisions underline strength in aerospac…
Director John M. Fahey Jr. sold 2,368 Class A shares of Johnson Outdoors Inc. (NASDAQ: JOUT) on March 17, 2026, for $44.63 each, totaling $105,683. The transaction occurred while the stock traded close to its 52-week high of $51.66 after an 84% year-over-year rise. In related corporate developments, the company reported fiscal Q1 2026 results that …
Seacoast Banking Corp of Florida director Hudson Dennis S III sold 8,000 shares on March 16, 2026, for $30.04 each under a Rule 10b5-1 plan, generating proceeds of $240,320. The bank’s stock trades near $29.84 with a $2.9 billion market capitalization. Separate fourth-quarter 2025 results showed revenue above expectations but an EPS miss, prompting…
Rodney A. Young, a director of CBIZ, Inc. (NYSE: CBZ), acquired 1,000 shares of the company's common stock on March 13, 2026, for $26,055. The purchase leaves Young with 9,310 directly held shares. The transaction occurs while CBIZ shares trade close to a 52-week low and after the company reported fourth-quarter revenue growth tied to the Marcum ac…
Sprinklr NASDAQ:CXM Chief Technology Officer Amitabh Misra sold 34,189 shares of Class A common stock on March 16, 2026, in a transaction disclosed on a Form 4. The sale, executed at a weighted average price between $5.765 and $5.91 and totaling about $200,005, was carried out to meet statutory tax-withholding obligations tied to recently granted r…
Booking Holdings Inc CEO Glenn D. Fogel sold 533 shares on March 16, 2026, generating roughly $2.87 million in proceeds. The trades, executed under a pre-established 10b5-1(c) plan, occur as the shares trade below six-month highs and the company faces both analyst upgrades tied to AI opportunities and regulatory probes into pricing algorithms.
Sprinklr Chief Marketing Officer Arun Pattabhiraman sold 32,500 Class A shares on March 16, 2026, in a company-mandated transaction to satisfy tax withholding tied to restricted stock unit vesting. The sale generated $190,125 at a weighted average price of $5.85. The transaction occurred as Sprinklr reported fiscal fourth-quarter results that beat …
SmartStop Self Storage REIT Director David J. Mueller sold 425 shares of common stock on March 16, 2026 under a Rule 10b5-1 trading plan, realizing $13,944 at $32.81 per share. Following the sale he directly holds 6,765.87 shares and retains significant Long-Term Incentive Plan (LTIP) units with staggered vesting schedules. The company reported fou…
Smith Douglas Homes Corp director George Ervin III bought 20,300 shares of the company’s Class A common stock on March 13, 2026, paying a weighted average price of $12.27 per share for a total of $249,011. The purchase raised his direct holdings to 60,684 shares amid recent earnings misses and a six-month stock decline.
Anne Kuykendall, Penguin Solutions' SVP and Chief Legal Officer, sold 4,000 shares on March 16, 2026 under a pre-arranged Rule 10b5-1 plan. The transaction totaled $70,980 at a weighted average price of $17.7452. The company has also disclosed partnerships to bolster voice AI infrastructure, CXL compliance for its memory module, and several senior …
New Jersey Resources Corp. CFO Roberto Bel sold 6,105 shares on March 16, 2026, through a pre-arranged Rule 10b5-1 plan, generating $336,376. The utility reported fiscal 2026 first-quarter earnings and revenue above Street estimates, while Raymond James raised its price target to $55 and kept an Outperform rating.
Omada Health CFO Steven L. Cook sold 1,884 shares on March 13, 2026, for $13.94 per share, totaling $26,262. The transaction was carried out under a 10b5-1 plan adopted in August 2025. The stock trades at $14.62, up nearly 4% over the past week but down roughly 35% year-over-year. Omada reported a Q4 2025 earnings beat, reached GAAP profitability f…
Nick V. Caldwell, Peloton Interactive's Chief Product Officer, sold 42,632 shares of Class A common stock on March 16, 2026, receiving $164,768 at a weighted average price of $3.8649 per share. The transactions follow a RSU exercise on March 15, 2026, and leave Caldwell with 880,956 direct shares. Peloton reported second-quarter fiscal 2026 sales o…
Michael P. Garthwaite, a vice president at Kinder Morgan, sold 1,550 shares of Class P common stock on March 16, 2026, under a 10b5-1 plan adopted December 9, 2025. The transaction totaled $51,608 at a weighted average price of $33.296. The company recently reported fourth-quarter 2025 results that beat select analyst and consensus forecasts, promp…
Oruka Therapeutics Chief Medical Officer Joana Goncalves sold 7,641 shares of company stock on March 16, 2026, under a pre-arranged 10b5-1 plan for roughly $312,559, while also exercising options for 7,000 shares. The transactions leave Goncalves with direct ownership of 33,377 shares. The moves come as the stock trades near a 52-week high and as O…
Senior Vice President of Finance Arjun Agarwal sold 395 shares of Oruka Therapeutics (NASDAQ: ORKA) on March 16, 2026, for $41.30 per share, generating $16,313 to satisfy tax-withholding tied to vested restricted stock units. The sale came as the stock trades near its 52-week high and after positive interim data and a string of analyst price-target…
